Clinical features associated with circulating concentration of soluble leptin receptor in patients with diabetes

被引:2
|
作者
Kotajima, N
Takahashi, T
Ito, H
Sumino, H
Fukumura, Y
Kurabayashi, M
Murakami, M
Kanda, T
机构
[1] Kanazawa Med Univ, Dept Gen Med, Uchinada, Ishikawa 9200293, Japan
[2] Gunma Univ, Sch Med, Dept Lab Med, Gunma, Japan
[3] Gunma Univ, Sch Med, Med Lab Ctr, Gunma, Japan
[4] Gunma Univ, Sch Med, Dept Internal Med 2, Gunma, Japan
关键词
soluble leptin receptor; leptin; body mass index; diastolic blood pressure; soluble tumour necrosis factor-alpha receptor 1;
D O I
10.1177/147323000503300105
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We aimed to determine if there were any clinical features that were significantly associated with the circulating concentration of soluble leptin receptor (OB-Re) in 67 Japanese subjects with diabetes mellitus. The characteristics evaluated included age, height, body weight, body mass index (BMI), systolic and diastolic blood pressure, duration of diabetes, haemoglobin A(1C) and blood lipid concentrations, urinary albumin excretion rate, circulating concentrations of leptin, tumour necrosis factor-a (TNF-alpha), TNF-a receptor 1 and genotypes of the angiotensin-converting enzyme (ACE) gene. We found statistically significant negative correlations between circulating OB-Re concentration and body weight, BMI, diastolic blood pressure, concentrations of leptin and TNF-alpha receptor 1. Serum OB-Re concentration was not associated with any of the other clinical characteristics that were measured, or with the different ACE genotypes. Our results suggest that OB-Re might have an important influence on the biological activity of leptin in diabetic subjects.
引用
收藏
页码:61 / 67
页数:7
相关论文
共 50 条
  • [41] Low Plasma Leptin and High Soluble Leptin Receptor Levels Are Associated With Mild Cognitive Impairment in Type 2 Diabetic Patients
    Yin, Han
    Tian, Sai
    Huang, Rong
    Cai, Rongrong
    Guo, Dan
    Lin, Hongyan
    Wang, Jiaqi
    Wang, Shaohua
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
  • [42] Serum leptin, soluble leptin receptor and ghrelin levels in multiple sclerosis and myasthenic patients
    Michalak, Slawomir
    Jernas, Lukasz
    Tokarz, Elzbieta
    Wygladalska-Jenas, Halina
    Kozubski, Wojciech
    NEUROLOGY, 2008, 70 (11) : A331 - A331
  • [43] Soluble leptin receptor levels in patients with chronic renal failure
    Krízová, J
    Sulková, S
    Bednárová, V
    Parízková, J
    Kotrlíková, E
    Haluzík, M
    PHYSIOLOGICAL RESEARCH, 2003, 52 (03) : 347 - 351
  • [44] The relation of leptin and soluble leptin receptor levels with metabolic and clinical parameters in obese and healthy children
    Catli, Gonul
    Anik, Ahmet
    Tuhan, Hale Unver
    Kume, Tuncay
    Bober, Ece
    Abaci, Ayhan
    PEPTIDES, 2014, 56 : 72 - 76
  • [45] Circulating SerpinB1 levels and clinical features in patients with type 2 diabetes
    Takebayashi, Kohzo
    Hara, Kenji
    Terasawa, Tomoko
    Naruse, Rika
    Suetsugu, Mariko
    Tsuchiya, Takafumi
    Inukai, Toshihiko
    BMJ OPEN DIABETES RESEARCH & CARE, 2016, 4 (01)
  • [46] Diurnal and ultradian dynamics of serum adiponectin in healthy men: Comparison with leptin, circulating soluble leptin receptor, and cortisol patterns
    Gavrila, A
    Peng, CK
    Chan, JL
    Mietus, JE
    Goldberger, AL
    Mantzoros, CS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06): : 2838 - 2843
  • [47] Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin -: Observational and interventional studies in humans
    Chan, JL
    Blüher, S
    Yiannakouris, N
    Suchard, MA
    Kratzsch, J
    Mantzoros, CS
    DIABETES, 2002, 51 (07) : 2105 - 2112
  • [48] Role of diabetes in influencing leptin concentration in elderly overweight patients
    Passaro, A
    Calzoni, F
    Zamboni, PF
    Manservigi, D
    Alberti, L
    Nora, ED
    Fellin, R
    Solini, A
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (02) : 173 - 179
  • [49] Role of soluble leptin receptor in diabetes prevention? Combination of cross-sectional, clinical intervention and Mendelian randomisation studies
    Sommer, C.
    Vangberg, K. G.
    Moen, G. -H.
    Evans, D. M.
    Lee-Odegard, S.
    Blom-Hogestol, I. K.
    Sletner, L.
    Jenum, A. K.
    Drevon, C. A.
    Gulseth, H. L.
    Birkeland, K. I.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S178 - S178
  • [50] Leptin and Soluble Leptin Receptor Levels in Plasma and Risk of Type 2 Diabetes in US Women A Prospective Study
    Sun, Qi
    van Dam, Rob M.
    Meigs, James B.
    Franco, Oscar H.
    Mantzoros, Christos S.
    Hu, Frank B.
    DIABETES, 2010, 59 (03) : 611 - 618